For many observers, the debate around proposed amendments to the Medical Aid Societies Regulations is framed as a question of principle: should medical aid societies provide healthcare services, or should they strictly remain financiers of care?
At first glance, the answer may seem obvious. In theory, medical aid societies exist to pool risk and pay for healthcare—not to operate clinics, pharmacies or laboratories. However, Zimbabwe’s healthcare landscape has never developed under ideal conditions. The reality is that the entry of medical aid societies into service provision was not a matter of choice, but of necessity.
Understanding that history is essential to informing the current regulatory debate.
A System Shaped by Gaps, Not Design
The presence of medical aid societies in healthcare delivery must be understood against a backdrop of structural shortages and economic instability. In a fully functioning public health system, private providers would consistently meet demand, leaving medical aid societies to play their conventional role as payers.
Zimbabwe has, at various points in its history, faced the opposite situation.
There have been periods where critical healthcare infrastructure—laboratories, clinics, and pharmacies—either collapsed or became unsustainable due to economic conditions and skills shortages. In such environments, the question was not whether medical aid societies should provide services, but whether anyone would.
The Laboratory Crisis: Protecting Access to Essential Diagnostics
- Mavhunga puts DeMbare into Chibuku quarterfinals
- Bulls to charge into Zimbabwe gold stocks
- Ndiraya concerned as goals dry up
- Letters: How solar power is transforming African farms
Keep Reading
One illustrative example dates back to the late 1980s and early 1990s. At the time, Zimbabwe had a limited number of diagnostic laboratories, with some operating as the only facilities available to large segments of the population.
When the professionals responsible for running one such laboratory—scientists and doctors—prepared to leave the country, the facility faced closure. There was no obvious private successor willing or able to take over operations. The market, in that moment, simply failed to provide continuity.
For a medical aid society like Cimas with thousands of members relying on diagnostic services, this presented an existential risk. Without access to laboratory testing, the entire chain of medical care breaks down—diagnosis becomes unreliable, treatment becomes delayed, and outcomes deteriorate.
In stepping in to acquire and preserve that facility, Cimas was not expanding into healthcare provision for strategic advantage. It was acting defensively, to ensure that its members were not left without access to essential services.
The 2004 Hyperinflation Shock: When the Payment Model Collapsed
A second, defining moment came in the early 2000s, particularly around 2004 during Zimbabwe’s period of hyperinflation.
The economic environment at the time made pricing extremely volatile. Costs changed rapidly—sometimes within hours—and providers struggled to operate under fixed or delayed reimbursement arrangements.
In response, many healthcare providers made a unilateral decision: they stopped accepting medical aid cards. Instead, they required patients to pay cash upfront and claim reimbursement later from their medical aid societies.
While understandable from a provider perspective, this fundamentally altered the risk structure for patients.
Members who had joined medical aid schemes precisely to avoid catastrophic out‑of‑pocket expenses suddenly found themselves exposed. Access to healthcare became contingent on immediate liquidity—something many families simply did not have.
Faced with this reality, medical aid societies had little choice but to intervene.
From Financiers to Providers: A Defensive Evolution
It is within this context that many medical aid societies expanded into healthcare service provision—establishing clinics, pharmacies, and diagnostic services.
These were not opportunistic expansions. They were necessary interventions aimed at:
* Restoring predictability in access to care
* Protecting members from out‑of‑pocket exposure
* Maintaining continuity of treatment
* Stabilising service delivery where private provision had become unreliable
In effect, service provision became an extension of the core mandate of medical aid societies: safeguarding their members’ access to healthcare.
The Equity Gap: Protecting Low‑Income Members
Equally important—but often overlooked—is the reality that medical aid societies serve not only higher‑income individuals, but also a significant number of low‑income earning members.
Many of these members are covered under basic packages, contributing as little as US$5 to US$20 per month. These products are designed to extend some level of healthcare access to those who would otherwise be excluded from private healthcare altogether.
However, the current pricing environment creates a fundamental mismatch.
With basic consultations in the private sector now typically costing US$30 to US$35 or more, low‑income members are placed at a structural disadvantage. Their contributions simply cannot sustain prevailing market charges.
The consequence is a form of indirect exclusion. Service providers, operating within a cost‑recovery framework, may charge fees well beyond what these packages can accommodate or may prioritise higher‑paying patients. While not always deliberate, the effect is clear: those who can least afford healthcare are the most likely to struggle to access it.
In principle, public healthcare institutions should fill this gap. However, due to years of underinvestment and capacity constraints, many public facilities are overstretched or unable to provide consistent and timely care.
This leaves a critical space unserved.
Faced with this reality, medical aid societies have had to create alternative pathways to ensure that low‑income members are not left without access to care. The establishment of parallel service provision—particularly in primary care clinics and pharmacies—has been one of the most practical responses.
These interventions allow societies to:
* Align the cost of care with low‑income contributions
* Provide predictable and affordable access to services
* Reduce the risk of exclusion and delayed treatment
* Ensure that even the most vulnerable members derive real value from their cover
Without such mechanisms, many low‑income members would effectively hold medical aid cover in name only—without meaningful access in practice.
Why This History Matters for Today’s Debate
The current proposals to restrict or eliminate the ability of medical aid societies to provide healthcare services must be assessed against this historical and social reality.
If the underlying challenges—provider shortages, cost pressures, and access barriers—have not been fully resolved, then removing service provision risks recreating the same vulnerabilities that led to its emergence.
This is particularly true for low‑income members, who are the most dependent on these alternative delivery models.
This is not an argument against regulation. There is, undoubtedly, a need to ensure:
* Transparency between funding and provision functions
* Fair competition within the healthcare sector
* Strong governance and accountability
However, regulation must be grounded in context, not theory alone.
A Balanced Way Forward
The question, therefore, is not whether medical aid societies should provide services in principle, but under what conditions such provision advances the public interest.
A balanced approach would recognise:
* The historical role played by medical aid societies in sustaining access
* The continued presence of structural gaps in healthcare delivery
* The need to protect vulnerable members from exclusion
In doing so, policymakers can strengthen the system without unintentionally weakening access to care.
Conclusion
Medical aid societies in Zimbabwe did not enter healthcare provision by design. They were compelled by circumstances—by market failure, by economic shocks, and by the need to protect their members when the conventional model broke down.
Today, as the country considers reforms to the regulatory framework, it is essential that this history is not overlooked.
Because at its core, this is not simply a policy debate. It is a question of access, equity, and the practical realities of healthcare delivery in Zimbabwe.
Policy that recognises these realities will be more resilient, more inclusive, and ultimately more aligned with the needs of the people it is intended to serve.
